Prediction of oligodendroglial tumor subtype and grade using perfusion weighted magnetic resonance imaging
- PMID: 17886561
- DOI: 10.3171/JNS-07/09/0600
Prediction of oligodendroglial tumor subtype and grade using perfusion weighted magnetic resonance imaging
Abstract
Object: Treatment of patients with oligodendrogliomas relies on histopathological grade and characteristic cytogenetic deletions of 1p and 19q, shown to predict radio- and chemosensitivity and prolonged survival. Perfusion weighted magnetic resonance (MR) imaging allows for noninvasive determination of relative tumor blood volume (rTBV) and has been used to predict the grade of astrocytic neoplasms. The aim of this study was to use perfusion weighted MR imaging to predict tumor grade and cytogenetic profile in oligodendroglial neoplasms.
Methods: Thirty patients with oligodendroglial neoplasms who underwent preoperative perfusion MR imaging were retrospectively identified. Tumors were classified by histopathological grade and stratified into two cytogenetic groups: 1p or 1p and 19q loss of heterozygosity (LOH) (Group 1), and 19q LOH only on intact alleles (Group 2). Tumor blood volume was calculated in relation to contralateral white matter. Multivariate logistic regression analysis was used to develop predictive models of cytogenetic profile and tumor grade.
Results: In World Health Organization Grade II neoplasms, the rTBV was significantly greater (p < 0.05) in Group 1 (mean 2.44, range 0.96-3.28; seven patients) compared with Group 2 (mean 1.69, range 1.27-2.08; seven patients). In Grade III neoplasms, the differences between Group 1 (mean 3.38, range 1.59-6.26; four patients) and Group 2 (mean 2.83, range 1.81-3.76; 12 patients) were not significant. The rTBV was significantly greater (p < 0.05) in Grade III neoplasms (mean 2.97, range 1.59-6.26; 16 patients) compared with Grade II neoplasms (mean 2.07, range 0.96-3.28; 14 patients). The models integrating rTBV with cytogenetic profile and grade showed prediction accuracies of 68 and 73%, respectively.
Conclusions: Oligodendroglial classification models derived from advanced imaging will improve the accuracy of tumor grading, provide prognostic information, and have potential to influence treatment decisions.
Similar articles
-
Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status.J Neurooncol. 2009 May;92(3):373-86. doi: 10.1007/s11060-009-9880-x. Epub 2009 Apr 9. J Neurooncol. 2009. PMID: 19357963
-
Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours.Neuroradiology. 2006 Oct;48(10):703-13. doi: 10.1007/s00234-006-0122-z. Epub 2006 Aug 26. Neuroradiology. 2006. PMID: 16937145 Free PMC article.
-
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.Clin Cancer Res. 2005 Feb 1;11(3):1119-28. Clin Cancer Res. 2005. PMID: 15709179
-
Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.Clin Neuropathol. 2006 Jan-Feb;25(1):18-24. Clin Neuropathol. 2006. PMID: 16465770
-
Prognostic markers for survival in patients with oligodendroglial tumors; a single-institution review of 214 cases.PLoS One. 2017 Nov 29;12(11):e0188419. doi: 10.1371/journal.pone.0188419. eCollection 2017. PLoS One. 2017. PMID: 29186201 Free PMC article. Review.
Cited by
-
Imaging characteristics of oligodendrogliomas that predict grade.AJNR Am J Neuroradiol. 2012 May;33(5):852-7. doi: 10.3174/ajnr.A2895. Epub 2012 Jan 19. AJNR Am J Neuroradiol. 2012. PMID: 22268087 Free PMC article.
-
Genetics and imaging of oligodendroglial tumors.CNS Oncol. 2015;4(5):307-15. doi: 10.2217/cns.15.37. Epub 2015 Oct 19. CNS Oncol. 2015. PMID: 26478219 Free PMC article. Review.
-
Revisiting oligodendroglioma grading in the 2021 WHO classification: calcification and larger contrast-enhancing tumor volume may predict higher oligodendroglioma grade.Neuroradiology. 2024 Sep;66(9):1527-1535. doi: 10.1007/s00234-024-03430-y. Epub 2024 Jul 17. Neuroradiology. 2024. PMID: 39014271
-
A systematic review and meta-analysis on the differentiation of glioma grade and mutational status by use of perfusion-based magnetic resonance imaging.Insights Imaging. 2022 Jun 7;13(1):102. doi: 10.1186/s13244-022-01230-7. Insights Imaging. 2022. PMID: 35670981 Free PMC article. Review.
-
Grading of oligodendroglial tumors of the brain with apparent diffusion coefficient, magnetic resonance spectroscopy, and dynamic susceptibility contrast imaging.Neuroradiol J. 2018 Aug;31(4):379-385. doi: 10.1177/1971400918757217. Epub 2018 Feb 22. Neuroradiol J. 2018. PMID: 29469659 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical